- letzte 200 News
- Archiv
| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| 10.04. | Cordel Group - PTC milestones crossed | 255 | Cordel's progress update on its Positive Train Control (PTC) development gives a good indication that the business is on track to open up a significant new revenue opportunity in the North American... ► Artikel lesen | ||
| 08.04. | BlackRock American Income Trust - Proposed change in investment strategy | 262 | BlackRock American Income Trust's (BRAI's) board has proposed a significant and innovative package of changes to adopt a systematic investment approach, which is a first in the investment trust sector.... ► Artikel lesen | ||
| 07.04. | AUSTRIACARD - FY24 net income growth of 20% | 279 | AUSTRIACARD's FY24 adjusted revenue and EBITDA met guidance, although slightly below our forecasts. Document lifecycle management and digital transformation technologies were the key drivers of revenue... ► Artikel lesen | ||
| 04.04. | Northern Data Group - Strategic alliance with Gcore | 669 | Northern Data has announced a new strategic partnership with Gcore, a leading provider of edge AI, cloud, network and security solutions. We see this as an important initiative, consistent with management's... ► Artikel lesen | ||
| 04.04. | Mendus (OMX: IMMU) presents DCOne platform update | 224 | On 3 April 2025, Mendus has announced that the company presented data from its proprietary DCOne platform at the Immunotherapy of Cancer Conference. The presentation showcased the potential of the platform... ► Artikel lesen | ||
| 04.04. | Immix Biopharma - All eyes on NEXICART-2 | 304 | Immix's FY24 results summarize a period of focus on its lead CAR-T asset, NXC-201, which is being developed for amyloid light chain amyloidosis. Recent newsflow reflects heightened clinical activity... ► Artikel lesen | ||
| 03.04. | Newron Pharmaceuticals - Pivotal evenamide trial looms | 484 | Newron Pharmaceuticals has published its FY24 results, reflecting a rewarding period for its lead clinical candidate, evenamide, which is being developed for treatment-resistant schizophrenia (TRS).... ► Artikel lesen | ||
| 03.04. | OSE Immunotherapeutics - Primed for value appreciation | 276 | OSE Immunotherapeutics is a clinical-stage immuno-oncology and immuno-inflammation company, with a pipeline spanning all stages of development. The company recently reported its FY24 results, reflecting... ► Artikel lesen | ||
| 03.04. | Moonpig - FY25 update shows continued cash generation | 253 | Moonpig's trading statement for FY25 (to end April) shows that the year looks set to finish in line or slightly better than expected. This is despite a challenging consumer confidence and geopolitical... ► Artikel lesen | ||
| 03.04. | Isofol (ST: ISOFOL) to receive financing to support Phase II & III trials of arfolitixorin in Japan | 229 | Isofol Medical has announced that Solasia Pharma, its development and commercialisation partner in Japan, intends to invest c SEK140m to support planned Phase II and III trials of arfolitixorin in the... ► Artikel lesen | ||
| 02.04. | Quadrise - Making waves | 289 | Quadrise raised £6.5m (before costs) in January through a placing and retail offer, increasing the company's cash reserves to £7.1m as of 28 February 2025. Management stated these funds will support... ► Artikel lesen | ||
| 02.04. | Topps Tiles (LSE:TPT) - volatile but improving trends through Q225 | 288 | Topps Tiles' H125 trading update indicates improving volume and revenue trends through Q225, with an exit rate of high-single-digit revenue growth in March 2025. There is a clear message that the Mission... ► Artikel lesen | ||
| 02.04. | Topps Tiles - Improving revenue growth through Q225 | 248 | Topps Tiles' H125 trading update indicates improving volume and revenue trends through Q225, with an exit rate of high-single-digit revenue growth in March 2025. There is a clear message that the Mission... ► Artikel lesen | ||
| 01.04. | Barton Gold - The Rubicon crossed - marching to production | 1.147 | Barton has continued to aggressively pursue its ambition to produce 125-150koz gold pa at Tunkillia via open pit production, completing a 5,064m reverse circulation drilling campaign targeting block... ► Artikel lesen | ||
| 01.04. | Picton Property Income - Further accretive sale completed | 239 | Picton Property Income (PCTN) has completed the £8.4m disposal of a vacant office building, which is to be redeveloped for student accommodation. The company completed three such sales in FY25, for... ► Artikel lesen | ||
| 01.04. | International Public Partnerships - Further measures to combat the discount | 241 | International Public Partnerships' (INPP's) results for the year ended 31 December 2024 show continuing strong operational performance, underpinning fully covered dividend growth. Primarily reflecting... ► Artikel lesen | ||
| 01.04. | 1Spatial - Kent County Council adopts 1Streetworks | 250 | 1Spatial has announced its third deal for its key 1Streetworks SaaS application, with Kent County Council (KCC). The deal is worth £0.5m over 12 months, further contributing to the company's positive... ► Artikel lesen | ||
| 01.04. | Pinewood (LSE: PINE) raises mid-term outlook | 243 | Pinewood reported results for the 11 months ended 31 December 2024 (FY24), having raised PBT expectations for FY24 in its February trading update. Compared to the corresponding 11 month period in 2023... ► Artikel lesen | ||
| 31.03. | Claranova - Better profitability in H125 | 297 | Claranova reported a 22% year-on-year improvement in adjusted EBITDA in H125, helped by improved profitability in both PlanetArt and Avanquest. We have upgraded our forecasts to reflect the better than... ► Artikel lesen | ||
| 31.03. | Murray International Trust - Fulfilling the income and capital growth mandate | 197 | Murray International Trust (MYI) is managed by Martin Connaghan and Samantha Fitzpatrick at Aberdeen Group. While FY24 results lagged those of its global reference index, the managers are fulfilling... ► Artikel lesen | ||
| 31.03. | Information Services Corporation - Record results and commitment to growth targets | 281 | Information Services Corporation (ISC) has completed its first full year post the announcement of its ambitious goal to double its size in terms of revenue and adjusted EBITDA (on an FY23 basis) by... ► Artikel lesen | ||
| 28.03. | VEON - 2025 - the year of the catalyst | 2.408 | VEON's Q424 results were robust, with revenues marginally ahead, EBITDA 11% ahead of our forecast and a lower-than-expected tax rate resulting in a 44% beat at the EPS level. VEON continues to aggressively... ► Artikel lesen | ||
| 28.03. | Amaroq Minerals - Amaroq 'n' roll | 331 | Amaroq's results to December 2024 were essentially just a pro-rata extrapolation of its earlier, nine-month results to September. More important was the fact that Nalunaq poured its first gold (39oz... ► Artikel lesen | ||
| 28.03. | OPAP - Online and sports drive big FY24 beat | 464 | OPAP enjoyed nothing short of a stellar Q424 as evidenced by the fact FY24's EBITDA was not only higher than management's guidance and our estimates, which were above the guided range, but also above... ► Artikel lesen | ||
| 28.03. | Recce Pharmaceuticals - Gearing up for an eventful year for R327G | 309 | Recce is preparing to start a registrational Indonesian Phase III study of the topical gel formulation (R327G) of its lead anti-infective therapeutic drug candidate, RECCE 327 (R327), for the treatment... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
